Eli Lilly to Acquire Ajax Therapeutics in Deal Worth Up to $2.3 Billion
By
Emma Clarke
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.